Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
3.910
+0.060 (1.56%)
Oct 30, 2025, 10:42 AM EDT - Market open
Salarius Pharmaceuticals Market Cap
Salarius Pharmaceuticals has a market cap or net worth of $1.99 million as of October 30, 2025. Its market cap has decreased by -0.36% in one year.
Market Cap
1.99M
Enterprise Value
1.17M
1-Year Change
-0.36%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since January 29, 2015, Salarius Pharmaceuticals's market cap has decreased from $254.50M to $1.99M, a decrease of -99.22%. That is a compound annual growth rate of -36.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 1.90M | -29.63% |
| Dec 31, 2024 | 2.70M | 3.85% |
| Dec 29, 2023 | 2.60M | -25.71% |
| Dec 30, 2022 | 3.50M | -84.38% |
| Dec 31, 2021 | 22.40M | 23.76% |
| Dec 31, 2020 | 18.10M | 17.53% |
| Dec 31, 2019 | 15.40M | 156.67% |
| Dec 31, 2018 | 6.00M | -90.45% |
| Dec 29, 2017 | 62.80M | -33.89% |
| Dec 30, 2016 | 95.00M | -57.44% |
| Dec 31, 2015 | 223.20M | -12.30% |
| Jan 29, 2015 | 254.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 450.37B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |